
Aidoc has raised $150M to accelerate development of its CARE foundation model for clinical AI in radiology and beyond.
Key Details
- 1Aidoc secured $150M in funding, bringing total raised to $370M since 2016.
- 2Investors include major U.S. hospital systems and venture capital firms; $40M is a revolving credit line.
- 3Funds will accelerate CARE, a clinical-grade foundation AI model adaptable across diseases.
- 4CARE aims to cover 90% of clinically relevant diseases within three years, including cancer and cardiovascular conditions.
- 5Aidoc supports decision-making for over 45 million patients annually across 150+ health systems.
- 6Company has over 20 FDA clearances and plans significant investment via partnerships with Nvidia and AWS.
Why It Matters
Aidoc's funding enables rapid development and scaling of foundational imaging AI, with potential to cover most clinically relevant diseases and support broader, system-wide AI adoption. Such progress could shift the landscape for radiologists and health systems, impacting workflow, diagnostics, and patient outcomes.

Source
Radiology Business
Related News

•Radiology Business
Aidoc Receives FDA Breakthrough Status for Multi-Condition CT AI Triage
Aidoc has received FDA Breakthrough Device status for its AI solution that flags multiple critical conditions in CT scans.

•AI in Healthcare
FDA Seeks Real-World Performance Insights on AI Medical Devices
FDA calls for healthcare worker feedback to enhance monitoring of AI-enabled medical devices in real-world settings.

•Health Imaging
Most FDA-Cleared AI Devices Lack Pre-Approval Safety Data, Study Finds
A new study finds fewer than 30% of FDA-cleared AI medical devices reported key safety or adverse event data before approval.